Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
62
KROS Quote, Financials, Valuation and Earnings
Last price:
$21.34
Seasonality move
:
4.91%
Day range:
$20.97 - $21.76
52-week range:
$9.12 - $22.55
Dividend yield:
0%
P/E ratio:
13.86x
P/S ratio:
3.52x
P/B ratio:
0.93x
Volume:
541K
Avg. volume:
1.1M
1-year change:
24.88%
Market cap:
$651.4M
Revenue:
$3.6M
EPS (TTM):
$1.54
Earnings Data
Next earnings date for KROS
Feb 25
2026
Most recent earnings per share
-$0.18
Beat by $0.74
(Nov 5/2025)
Consensus Estimate
-$0.92
(Nov 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
KROS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/25/2026 | Q4 | $3.7M | -- | -- | -$0.44 | -- |
| 11/05/2025 | Q3 | $4.2M | $14.3M | -$0.18 | -$0.92 | $0.74 |
| 08/07/2025 | Q2 | $4.2M | $18.2M | -$0.76 | -$1.13 | $0.37 |
| 05/07/2025 | Q1 | $56.6M | $211.2M | $3.62 | $0.01 | $3.61 |
| 02/26/2025 | Q4 | $37.3M | $3M | -$1.14 | -$0.43 | -$0.71 |
| 11/06/2024 | Q3 | -- | $388K | -$1.41 | -$1.28 | -$0.13 |
| 08/07/2024 | Q2 | -- | $37K | -$1.25 | -$1.25 | -$0.00 |
| 05/08/2024 | Q1 | -- | $83K | -$1.21 | -$1.33 | $0.13 |
| 02/28/2024 | Q4 | -- | $143K | -$1.34 | -$1.39 | $0.06 |
| 11/06/2023 | Q3 | -- | $8K | -$1.33 | -$1.35 | $0.02 |
| 08/07/2023 | Q2 | -- | -- | -$1.27 | -- | -- |
| 05/04/2023 | Q1 | -- | -- | -$1.26 | -- | -- |
| 03/03/2023 | Q4 | -- | -- | -$1.09 | -- | -- |
| 11/03/2022 | Q3 | -- | -- | -$0.92 | -- | -- |
| 08/04/2022 | Q2 | -- | -- | -$1.13 | -- | -- |
| 05/05/2022 | Q1 | -- | -- | -$1.01 | -- | -- |
| 03/09/2022 | Q4 | -- | $20M | -$0.30 | -- | -- |
| 11/04/2021 | Q3 | -- | -- | -$0.87 | -- | -- |
| 08/05/2021 | Q2 | -- | $100K | -$0.67 | -- | -- |
| 05/06/2021 | Q1 | -- | -- | -$0.68 | -- | -- |
| 03/25/2021 | Q4 | -- | -- | -$0.49 | -- | -- |
| 11/10/2020 | Q3 | -- | -- | -$0.60 | -- | -- |
| 08/13/2020 | Q2 | -- | -- | -$0.62 | -- | -- |
| 05/22/2020 | Q1 | -- | -- | -$0.63 | -- | -- |
| 12/31/2019 | Q4 | -- | $2.5M | -$0.18 | -- | -- |
| 09/30/2019 | Q3 | -- | $2.5M | -$0.20 | -- | -- |
| 06/30/2019 | Q2 | -- | $2.5M | -$1.44 | -- | -- |
| 03/31/2019 | Q1 | -- | $2.5M | -$0.18 | -- | -- |
Keros Therapeutics, Inc. Earnings Questions
-
How Much did Keros Therapeutics, Inc. Generate in Revenue Last Quarter?
Keros Therapeutics, Inc. reported $14.3M worth of top line sales in its most recent quarter.
-
Did Keros Therapeutics, Inc. Beat Earnings Last Quarter?
Keros Therapeutics, Inc. announced earnings per share of -$0.18 which represents a beat of analyst forecast a -$0.92 per share.
-
Is Keros Therapeutics, Inc. Profitable?
Keros Therapeutics, Inc. reported $13.9M that represents $0.34 per share over the last quarter.
-
What is the Analyst Consensus for Keros Therapeutics, Inc. EPS Next Year?
Keros Therapeutics, Inc.'s earnings are forecast to decrease from -$5.00 per share to -$4.12 per share next year representing a decrease of -97.1%.
-
When is Keros Therapeutics, Inc.'s Earnings Date?
Keros Therapeutics, Inc.'s next earnings date is February 25, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
